Your browser doesn't support javascript.
loading
Characteristics, Treatment Patterns, and Economic Outcomes of Patients Initiating Injectable Medications for Management of Type 2 Diabetes Mellitus in Japan: Results from a Retrospective Claims Database Analysis.
Suzuki, Shuichi; Desai, Urvi; Strizek, Alena; Ivanova, Jasmina; Garcia-Horton, Viviana; Cai, Zhihong; Schmerold, Luke; Liu, Xinyue; Perez-Nieves, Magaly.
Affiliation
  • Suzuki S; Eli Lilly Japan, K.K., Kobe, Japan. Suzuki_shuichi@lilly.com.
  • Desai U; Analysis Group, Inc., Boston, MA, USA.
  • Strizek A; Eli Lilly and Company, Indianapolis, IN, USA.
  • Ivanova J; Analysis Group, Inc., New York, NY, USA.
  • Garcia-Horton V; Analysis Group, Inc., New York, NY, USA.
  • Cai Z; Eli Lilly Japan, K.K., Kobe, Japan.
  • Schmerold L; Analysis Group, Inc., New York, NY, USA.
  • Liu X; Analysis Group, Inc., New York, NY, USA.
  • Perez-Nieves M; Eli Lilly and Company, Indianapolis, IN, USA.
Diabetes Ther ; 9(3): 1125-1141, 2018 Jun.
Article in En | MEDLINE | ID: mdl-29663262
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Health_economic_evaluation / Risk_factors_studies Language: En Journal: Diabetes Ther Year: 2018 Document type: Article Affiliation country: Japan Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Health_economic_evaluation / Risk_factors_studies Language: En Journal: Diabetes Ther Year: 2018 Document type: Article Affiliation country: Japan Country of publication: United States